Regeneron to Acquire 23andMe in Court-Supervised Sale, Promises to Maintain Privacy Policies | AI News Brew <p>SAN FRANCISCO - In a significant development in the biotechnology sector, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has entered into a definitive agreement to acquire 23andMe Holding Co. (OTC:...

Regeneron to Acquire 23andMe in Court-Supervised Sale, Promises to Maintain Privacy Policies
ainewsbrew.com/article/4248

#Regeneron #23andMe #BiotechAcquisition #GeneticPrivacy #PharmaTakeover